Midecamycin
Systematic (IUPAC) name | |
---|---|
(2S,3S,4R,6S)-6-{[(2R,3S,4R,5R,6S)-4-(dimethylamino)-5-hydroxy-6-{[(4R,6S,7R,9R,10R,11E,13E,16R)-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-4-(propanoyloxy)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy}-2-methyloxan-3-yl]oxy}-4-hydroxy-2,4-dimethyloxan-3-yl propanoate | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Identifiers | |
CAS Number | 35457-80-8 |
ATC code | J01FA03 (WHO) |
PubChem | CID 5382853 |
ChemSpider | 4445365 |
UNII | N34Z0Y5UH7 |
KEGG | D01339 |
Chemical data | |
Formula | C41H67NO15 |
Molar mass | 813.968 g/mol |
| |
| |
Physical data | |
Melting point | 155 to 156 °C (311 to 313 °F) |
Solubility in water | Soluble in acidic/low pH water; Very soluble in methanol, chloroform, ethyl acetate, benzene, ethyl ether; Almost completely in ethanol(>95.5) mg/mL (20 °C) |
(verify) |
Midecamycin is a macrolide antibiotic. Synthesized from Streptomyces mycarofaciens.
Physical Properties
Melting point vary depending on the compound type. It may also vary depending on the source consulted. Example:
For the A1 type:
The Merck Index reports 155-156 Celsius. The Japanese Pharmacopoeia reports 153–158 Celsius.
For the A3 type:
The Merck Index reports 122-125 Celsius.
|
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.